ABSTRACT Mediators of hormone and neurotransmitter action may exert negative control on the accumulation of one another (adenosine 3':5'-cyclic monophosphate vs calcium or guanosine 3':5'-cyclic monophosphate, or conversely). A model in which one agonist stimulates the formation of two mediators which inhibit each other's accumulation has been simulated. Three types of agonist-receptor interaction, five mechanisms of inhibition, and three types of basal activity have been considered which lead to a set of 45 descriptions of the general cross inhibition model. For these submodels, patterns of the relation of agonist to mediator concentrations at steady state conditions have been defined. Some patterns are complex with mediator curves exhibiting extrema, one a maximum and the other a minimum. The complexity of the pattern depends on the submodel and on the degree of asymmetry between the parameters of each of the mediator pathways (e.g., affinities for the agonist, strength of the inhibitions, etc.). This simple model can thus account for complex experimental results without requiring the postulation of elaborate molecular models of agonist-receptor interaction. The simulations presented emphasize the necessity of investigating a wide range of agonist concentrations. Recent findings have increased the complexity of concepts of the control of cell metabolism by hormones and neurotransmitters. An increasing body of evidence suggests that some agonists can stimulate a target cell simultaneously through more than one receptor and mediator (1-11). One type of agonistreceptor interaction leads to an increase in the activity of adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.11 and in the intracellular content of adenosine 3':5'-cyclic monophosphate (cAMP) (12) . Another type, at least in some cases, seems to lead to an increase in the cytoplasmic calcium concentration resulting from increased influx or from release from an intracellular store (7, 8) . A variety of agents that can increase cytoplasmic calcium can also increase levels of guanosine 3':5'-cyclic monophosphate (cGMP) (10, (13) (14) (15) (16) (17) .
appears to stimulate one form of cyclic nucleotide phosphodiesterase (19) (20) (21) (22) and to inhibit adenylate cyclase from many tissues (8, 23, 24) . Conversely, cAMP appears to stimulate the removal of calcium from the cytoplasm of myocardium (25, 26) and perhaps smooth muscle (27, 28) by promoting the uptake of the cation by intracellular structures, and it may stimulate the efflux of calcium from liver (29, 30) and thyroid (31) . cGMP can stimulate the degradation of cAMP by some phosphodiesterases (32) (33) (34) . Negative interactions between cAMP and calcium or cGMP thus seem to occur frequently.
These findings suggest that a tentative description of hormone or neurotransmitter action in some tissues would be a model in which one agonist stimulates the formation of two mediators which interact through cross inhibitions (Fig. 1) . The agonist H, synthesized and degraded outside its target cell, binds to two different receptors, RI and R2, and thereby stimulates the synthesis or release of mediator X from precursor pool A and mediator Y from precursor pool C. X and Y are degraded or inactivated inside the cell. X inhibits the accumulation of Y and vice-versa. Mediator X could correspond to cAMP, A representing the ATP pool, whereas mediator Y could correspond either to cGMP or to free intracellular calcium, C representing, respectively, either the GTP pool, or a sequestrated or extracellular calcium pool. Implications of this model, apparently a very simple one, are almost impossible to work out intuitively. This paper presents simulations of such a model and .shows its possible behaviors and consequences. Levels of mediators may change in response to varying concentrations of an agonist in highly complex and unexpected ways. To obtain results of the most general nature, several types of receptor and inhibition mechanisms have been combined, and a set of submodels, all corresponding to the representation of Fig. 1 R and E, respectively. The total concentration and the affinity for the hormone completely characterize the receptor, once its mechanism is defined. The affinity is given by the equilibrium constant of the binding reaction for mechanisms (a) and (b) and by the product of the equilibrium constants of the two steps for mechanism (c). In certain cases, the number of receptor subunits may exceed the number of effector subunits (35) (36) (37) 
RESULTS
The set of possible patterns for the simulated concentrationresponse curves of a model with basal activities sensitive to cross inhibitions is shown in Fig. 2 . Three types of behavior are possible: no extremum occurring (I), one extremum occurring (II), and two extrema occurring (III). In Fig. 2 , IA, both X and Y increase monotonously when the agonist concentration increases. These concentration-response curves are no more complex than would be observed if there were no interactions between the two pathways. The only effect of the cross-inhibitions is to avoid saturation of the system until extremely large hormone concentrations are present. The cell thus remains sensitive to the agonist concentration over a much larger range. In Fig. 2 , IB, one of the species increases, whereas the other decreases. Although the synthesis of both species is stimulated by the agonist, the cross-inhibitions strongly favor the accumulation of one of the species which thereby prevents the increase of the other. This pattern is possible only for models with basal activities affected by the cross-inhibitions. In Fig. 2 , II, one of the species undergoes an extremum, whereas the other steadily increases when the agonist concentration increases. In pattern IIA, X and Y increase in part 1 of the range of concentration of H, and then the species having experienced the steepest increase in part 1 decreases in part 2. In pattern IIB, one of the variables displays a minimum. In Fig. 2 (9, (35) (36) (37) . For all models, elementary calculations show that totally symmetric characteristics (same number of both receptors, same affinity for the hormone, same rates of synthesis and of degradation, same inhibitory parameters) result in superimposed curves for X and Y. Thus, asymmetrical conditions could be viewed as "nonredundancy" conditions, perhaps necessary for optimal coordination of the total cellular response.
Concentration-response curves exhibiting extrema are certainly not specific for the cross-inhibition model of Fig. 1 
